Edesa Biotech, Inc. — Form D

Edesa Biotech, Inc. of MARKHAM, A6, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-31. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2012-10-31
• Form: D
• Accession: 0001540159-12-000002
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $1.0M
• Amount sold: $1.0M
• Investors: 3
• Date of first sale: 2012-10-25
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-186328

Issuer

• Name: Edesa Biotech, Inc.
• CIK: 0001540159
• Entity type: Corporation
• Jurisdiction: BRITISH COLUMBIA, CANADA
• Incorporated: 2007
• Address: 100 SPY COURT, MARKHAM, A6, L3R 5H6
• Phone: 289-800-9600

Officers, directors & promoters (47)

Showing 25 of 47 people.

Other filings by this issuer (8)

More

• CIK 1540159 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search